<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02289846</url>
  </required_header>
  <id_info>
    <org_study_id>ICP-112-202</org_study_id>
    <nct_id>NCT02289846</nct_id>
  </id_info>
  <brief_title>Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)</brief_title>
  <official_title>A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Study of Oral IW-9179 Administered Once and Twice Daily for 4 Weeks to Patients With Diabetic Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ironwood Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ironwood Pharmaceuticals, Inc.</source>
  <brief_summary>
    <textblock>
      The objectives of this study are to evaluate the safety of IW-9179 in patients with diabetic
      gastroparesis (DGP) and the effect of treatment on the cardinal symptoms of DGP.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exploratory Endpoint - Daily Severity of Patient-reported Diabetic Gastroparesis Symptoms</measure>
    <time_frame>Change from baseline: Treatment Period (weeks 1-4) compared with 2-week (baseline) Pretreatment Period</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Diabetic Gastroparesis</condition>
  <arm_group>
    <arm_group_label>Placebo BID</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo once in the morning and once in the evening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IW-9179 QD AM + Placebo QD PM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IW-9179 once in the morning and placebo once in the evening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo QD AM + IW-9179 QD PM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo once in the morning and IW-9179 once in the evening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IW-9179 BID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IW-9179 once in the morning and once in the evening</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IW-9179</intervention_name>
    <arm_group_label>IW-9179 QD AM + Placebo QD PM</arm_group_label>
    <arm_group_label>Placebo QD AM + IW-9179 QD PM</arm_group_label>
    <arm_group_label>IW-9179 BID</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Matching Placebo</intervention_name>
    <arm_group_label>Placebo BID</arm_group_label>
    <arm_group_label>IW-9179 QD AM + Placebo QD PM</arm_group_label>
    <arm_group_label>Placebo QD AM + IW-9179 QD PM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is a male or non-pregnant, non-breastfeeding female, and is age 18 years or
             older at the time of the Screening Visit.

          -  Patient has a confirmed diagnosis of type 1 or type 2 diabetes mellitus.

          -  Patient has a diagnosis of DGP with no history or evidence of mechanical obstruction,
             symptoms for at least 3 consecutive months preceding the Screening Visit, and delayed
             gastric emptying of solids documented within 2 years of the Screening Visit.

          -  Patient has a normal EGD either during the Screening Period or within 2 years of the
             Screening Visit, with no evidence of structural or organic disease that may explain
             the patient's gastroduodenal symptoms.

          -  Patient is compliant with eDiary completion.

          -  Patient agrees to refrain from making any new, major lifestyle changes.

          -  Patient is fluent and literate in English.

        Exclusion Criteria:

          -  Patient has a history or current symptoms of any organic or structural disease that,
             in the opinion of the investigator, can cause abdominal pain or discomfort and may
             confound the assessment of DGP symptoms.

          -  Patients with rumination syndrome, cyclic vomiting syndrome, anorexia nervosa, or
             bulimia.

          -  Patient is currently using a gastric electric stimulator or has had endoscopic pyloric
             injections of botulinum toxin within the 6 months prior to the Screening Visit.

          -  Patient has been hospitalized within the 2 months prior to the Screening Visit for
             uncontrolled diabetes mellitus, DGP, or associated malnutrition.

          -  Patient reports significant diarrhea during the four weeks prior to the Screening
             Visit, or more than 2 days during either week of the Pretreatment Period.

          -  Patient has had surgery of the GI tract any time before the Screening Visit, an
             appendectomy or cholecystectomy during the 3 months before the Screening Visit, non-GI
             surgery of the abdomen, pelvis, or retroperitoneal structures during the 6 months, or
             other major non-GI surgery during the 30 days before the Screening Visit.

          -  Patient has a history of cancer (resected basal cell or squamous cell carcinoma of the
             skin is acceptable).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <zip>36305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>North Little Rock</city>
        <state>Arkansas</state>
        <zip>72117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Bastrop</city>
        <state>Louisiana</state>
        <zip>71220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Chesterfield</city>
        <state>Michigan</state>
        <zip>48047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <zip>77598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ironwood Investigational Site</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2014</study_first_submitted>
  <study_first_submitted_qc>November 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2014</study_first_posted>
  <disposition_first_submitted>December 1, 2016</disposition_first_submitted>
  <disposition_first_submitted_qc>December 1, 2016</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">December 5, 2016</disposition_first_posted>
  <last_update_submitted>December 1, 2016</last_update_submitted>
  <last_update_submitted_qc>December 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

